Home » ABI Sues Stratagene in Europe for Allegedly Infringing qPCR Patent

ABI Sues Stratagene in Europe for Allegedly Infringing qPCR Patent

May 30, 2007
NEW YORK (GenomeWeb News) — Applied Biosystems' parent company has sued Stratagene in the Netherlands and France for allegedly infringing an ABI patent, Stratagene said in a filing with the US Securities and Exchange Commission yesterday.
 
According to the filing, on May 23 Stratagene received a writ of summons filed by Applera in the District of The Hague in the Netherlands alleging that Stratagene's Mx3000P, Mx3005P, Mx4000P, and "certain related reagents" infringe ABI’s EU patent No. 0 872 562 B1.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.